Medical Tourism Market

Executive Summary

Medical Tourism Market was valued at US $22,581.90 million in 2021 and is projected to grow at 20.76% CAGR over the forecast period to reach US $70,028.28 million by 2027. Medical Tourism Market represented US $7,096.49 million opportunity over 2019-2021 and estimated to create US $47,446.38 million opportunity in 2027 over 2021.

Medical Tourism from Consainsights analyses the Medical Tourism Market in the Life Sciences industry over the forecast period to 2027.

Medical Tourism research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Medical Tourism segmentation includes Treatment Type and Geography.

Based on the Treatment Type, the Medical Tourism analysis covers Cosmetic Treatment, Dental Treatment, Cardiovascular Treatment, Orthopedics Treatment, Bariatric Surgery, Fertility Treatment, Ophthalmic Treatment, Other Treatments.

In Treatment Type segment, Cosmetic Treatment segment has highest cagr growth of 18.25%.

Based on the region, the Medical Tourism analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include Medretreat, Healthbase, Apollo Hospitals, KPJ Healthcare Behard, Klinikum Medical Link, Euromedical Tours, BB Health Solutions, Cosmedic Travel and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Treatment Type

Introduction

In 2021, Cosmetic Treatment segment has the highest revenue of US $8,843.11 million and is expected to grow at CAGR of 18.25% by 2027 Cosmetic Treatment segment has highest cagr growth of 18.25%.

Cosmetic Treatment

Cosmetic Treatment segment was valued at US $6,064.11 million in 2019 and is projected to grow at 18.25% CAGR over the forecast period to reach US $27,423.20 million by 2027. Cosmetic Treatment segment represented US $2,779.00 million opportunity over 2019-2021 and estimated to create US $18,580.09 million opportunity in 2027 over 2021.

Dental Treatment

Dental Treatment segment was valued at US $3,821.55 million in 2019 and is projected to grow at 18.25% CAGR over the forecast period to reach US $17,281.87 million by 2027. Dental Treatment segment represented US $1,751.30 million opportunity over 2019-2021 and estimated to create US $11,709.01 million opportunity in 2027 over 2021.

Cardiovascular Treatment

Cardiovascular Treatment segment was valued at US $2,166.58 million in 2019 and is projected to grow at 18.25% CAGR over the forecast period to reach US $9,797.72 million by 2027. Cardiovascular Treatment segment represented US $992.88 million opportunity over 2019-2021 and estimated to create US $6,638.27 million opportunity in 2027 over 2021.

Orthopedics Treatment

Orthopedics Treatment segment was valued at US $1,453.83 million in 2019 and is projected to grow at 18.25% CAGR over the forecast period to reach US $6,574.53 million by 2027. Orthopedics Treatment segment represented US $666.25 million opportunity over 2019-2021 and estimated to create US $4,454.45 million opportunity in 2027 over 2021.

Bariatric Surgery

Bariatric Surgery segment was valued at US $737.48 million in 2019 and is projected to grow at 18.25% CAGR over the forecast period to reach US $3,335.02 million by 2027. Bariatric Surgery segment represented US $337.96 million opportunity over 2019-2021 and estimated to create US $2,259.59 million opportunity in 2027 over 2021.

Fertility Treatment

Fertility Treatment segment was valued at US $615.66 million in 2019 and is projected to grow at 18.25% CAGR over the forecast period to reach US $2,784.15 million by 2027. Fertility Treatment segment represented US $282.14 million opportunity over 2019-2021 and estimated to create US $1,886.35 million opportunity in 2027 over 2021.

Ophthalmic Treatment

Ophthalmic Treatment segment was valued at US $416.82 million in 2019 and is projected to grow at 18.25% CAGR over the forecast period to reach US $1,884.95 million by 2027. Ophthalmic Treatment segment represented US $191.02 million opportunity over 2019-2021 and estimated to create US $1,277.11 million opportunity in 2027 over 2021.

Other Treatments

Other Treatments segment was valued at US $209.37 million in 2019 and is projected to grow at 18.25% CAGR over the forecast period to reach US $946.84 million by 2027. Other Treatments segment represented US $95.95 million opportunity over 2019-2021 and estimated to create US $641.51 million opportunity in 2027 over 2021.